LPTX
Leap Therapeutics Inc.
$0.31
+$0.02(+6.18%)
10
Overall
--
Value
10
Tech
--
Quality
Market Cap
$12.01M
Volume
870.06K
52W Range
$0.22 - $4.79
Target Price
$1.25
Order:
Income Statement
| Metric | Trend | Chart | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||
| Total Revenue | -- | -- | -- | $1.5M | $1.5M | -- | -- | -- | ||
| Total Revenue | -- | -- | -- | $1.5M | $1.5M | -- | -- | -- | ||
| GROSS PROFIT | ||||||||||
| Gross Profit | -- | -- | -- | $1.5M | $1.5M | -- | -- | -- | ||
| OPERATING EXPENSES | ||||||||||
| Operating Expenses | $-32.4M | $-30.8M | $-33.5M | $30.0M | $42.9M | $54.7M | $87.0M | $70.1M | ||
| Research & Development | $22.5M | $21.8M | $24.4M | $20.4M | $32.2M | $45.0M | $73.2M | $57.2M | ||
| Research Expense | $22.5M | $21.8M | $24.4M | $20.4M | $32.2M | $45.0M | $73.2M | $57.2M | ||
| Selling, General & Administrative | $9.8M | $8.9M | $9.1M | $9.6M | $10.8M | $11.8M | $13.8M | $12.8M | ||
| General & Administrative Expenses | $9.8M | $8.9M | $9.1M | $9.6M | $10.8M | $11.8M | $13.8M | $12.8M | ||
| Salaries & Wages | $-5.6M | $-3.5M | $-3.7M | $2.6M | -- | -- | -- | -- | ||
| Depreciation & Amortization | $-48.0K | $-49.0K | $-47.0K | $34.0K | $29.0K | $16.0K | $15.0K | $5.0K | ||
| Depreciation & Amortization | $-48.0K | $-49.0K | $-47.0K | $34.0K | $29.0K | $16.0K | $15.0K | $5.0K | ||
| Amortization | -- | -- | -- | $135.0K | $135.0K | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | $549.0K | $423.0K | $443.0K | $449.0K | $461.0K | ||
| OPERATING INCOME | ||||||||||
| Operating income | $-32.4M | $-30.8M | $-33.5M | $-28.5M | $-41.4M | $-56.8M | $-87.0M | $-70.1M | ||
| EBITDA | $-29.2M | $-23.1M | $-32.8M | $-26.8M | $-40.5M | $-54.4M | $-81.0M | $-66.5M | ||
| NON-OPERATING ITEMS | ||||||||||
| Interest Expense (Non-Operating) | $649.0K | $19.0K | $23.0K | $39.0K | $41.0K | $54.0K | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $-649.0K | $-19.0K | $-23.0K | $-39.0K | $-41.0K | $-871.0K | $-4.0M | -- | ||
| Other Income/Expense | $-473.0K | $-7.3M | -- | $303.0K | -- | $-608.0K | $-500.0K | $234.0K | ||
| Other Special Charges | $473.0K | $7.3M | -- | $-303.0K | -- | -- | $500.0K | -- | ||
| PRE-TAX INCOME | ||||||||||
| EBIT | $-29.2M | $-23.1M | $-32.9M | $-27.5M | $-40.6M | $-54.4M | $-81.4M | $-67.0M | ||
| Pre-Tax Income | $-29.9M | $-23.1M | $-32.9M | $-27.5M | $-40.6M | $-54.4M | $-81.4M | $-67.0M | ||
| INCOME TAX | ||||||||||
| Tax Provision | $-157.0K | $20.0K | $-3.0K | $-2.0K | $-24.0K | $147.0K | -- | $585.0K | ||
| NET INCOME | ||||||||||
| Net Income | $-31.6M | $-24.3M | $-33.3M | $-27.5M | $-40.6M | $-54.6M | $-81.4M | $-67.6M | ||
| Net Income (Continuing Operations) | $-31.6M | $-24.3M | $-33.3M | $-27.5M | $-40.6M | $-54.6M | $-81.4M | $-67.6M | ||
| Net Income (Discontinued Operations) | $-31.6M | $-24.3M | $-33.3M | $-27.5M | $-40.6M | $-54.6M | $-81.4M | $-67.6M | ||
| Net Income (Common Stockholders) | $-31.9M | $-24.3M | $-33.7M | $-37.6M | $-40.6M | $-54.6M | $-81.4M | $-67.6M | ||
| Normalized Income | -- | -- | -- | -- | $-40.6M | -- | -- | $-66.1M | ||
| TOTALS | ||||||||||
| Total Expenses | $-32.4M | $-30.8M | $-33.5M | $30.0M | $42.9M | $54.7M | $87.0M | $70.1M | ||
| SHARE & EPS DATA | ||||||||||
| Average Shares Outstanding | $916.2K | $1.4M | $2.3M | $5.9M | $8.6M | $11.3M | $20.4M | $37.6M | ||
| Average Shares Outstanding (Diluted) | $918.9K | $1.4M | $2.3M | $5.9M | $8.6M | $11.3M | $20.4M | $37.6M | ||
| Shares Outstanding | $41.4M | $41.4M | $3.6M | $6.0M | $8.8M | $11.9M | $25.6M | $41.3M | ||
| Basic EPS | $-32.7 | $-16.4 | $-14.7 | $-6.3 | $-4.7 | $-4.8 | $-3.98 | $-1.81 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | $-6.3 | $-4.7 | $-4.8 | $-3.98 | $-1.81 | ||
| Diluted EPS | $-33.1 | $-21.1 | $-14.7 | $-6.3 | $-4.7 | $-4.8 | $-3.98 | $-1.81 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | $-6.3 | $-4.7 | $-4.8 | $-3.98 | $-1.81 | ||
| OTHER METRICS | ||||||||||
| Accretion On Preferred Stock | $244.0K | -- | -- | -- | -- | -- | -- | -- | ||
| Accrued Preferred Stock Dividends | -- | -- | $359.0K | $9.8M | -- | -- | -- | -- | ||
| Other Gand A | $9.8M | $8.9M | $9.1M | $9.6M | $10.8M | $11.8M | $13.8M | $12.8M | ||
| Other Write Off | -- | -- | -- | -- | -- | -- | -- | $234.0K | ||
| Otherunder Preferred Stock Dividend | $244.0K | -- | $359.0K | $9.8M | -- | -- | -- | -- | ||
| Preferred Stock Dividends | $244.0K | -- | $359.0K | $9.8M | -- | -- | -- | -- | ||
| Rent And Landing Fees | $9.8M | $8.9M | $9.1M | $549.0K | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LPTX | $0.31 | +6.2% | 870.06K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |